Welcome to our dedicated page for Solesence news (Ticker: SLSN), a resource for investors and traders seeking the latest updates and insights on Solesence stock.
Solésence, Inc. (Nasdaq: SLSN) is a scientifically driven health care solutions company in the household and personal products space, focused on beauty and life science categories. Company news frequently centers on its mineral-based skin care, sun care and color cosmetics activities, which it positions around skin health, aesthetics and daily wearability.
Investors following SLSN news can expect regular updates on financial performance, including quarterly earnings results, revenue trends and gross margin commentary, as reflected in the company’s first, second and third quarter 2025 press releases. These announcements often discuss shipment and production volumes, non-GAAP measures such as adjusted EBITDA, and the impact of operational changes on profitability.
Solésence also issues news about corporate developments, such as its rebranding from Nanophase Technologies to Solésence, its uplisting to Nasdaq under the SLSN ticker, and its inclusion in the Russell 3000 and Russell 2000 indexes. Leadership changes are another recurring theme, including the promotion of Kevin Cureton to President and Chief Executive Officer, the appointment of Laura Riffner as Chief Financial Officer, and the creation of a Vice President of Innovation and Product Integrity role.
Operational and strategic updates appear in releases about manufacturing consolidation, increased automation, expanded debt facilities, and the unification of research and development, product development, regulatory and quality functions. For those tracking the intersection of beauty and skin health, Solésence news also highlights intellectual property milestones and recognition within the beauty industry. This page aggregates such company-issued information so readers can monitor how Solésence describes its progress and strategic direction over time.
Solésence (Nasdaq: SLSN), a leader in scientifically-driven health care solutions focusing on beauty and life science categories, has scheduled its first quarter 2025 financial results announcement and conference call.
Key Details:
- Results Release: Monday, May 5, 2025, after market close
- Conference Call Time: 4:00 p.m. CDT / 5:00 p.m. EDT
- Key Speakers: Jess Jankowski (President & CEO) and Kevin Cureton (Chief Operating Officer)
Participants can access the conference call through multiple channels:
- Webcast: Available via media server link
- Dial-in: Registration required for personalized PIN
- Company Website: Accessible through investor relations page
Interested parties are advised to join the call at least five minutes before the start time. The company has provided convenient registration options, including an automatic dial-out feature once the conference begins.